STOCK TITAN

Haleon (NYSE: HLN) details total voting rights and share capital update

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc reports its share capital and voting rights position as at 31 March 2026. The company has issued 8,931,093,261 ordinary shares of £0.01 each, of which 12,548,735 are held in treasury. This leaves 8,918,544,526 ordinary shares carrying voting rights, which shareholders should use as the denominator when assessing whether they must notify holdings or changes in holdings under the FCA's Disclosure Guidance and Transparency Rules.

Positive

  • None.

Negative

  • None.
Ordinary shares issued 8,931,093,261 shares Ordinary shares of £0.01 each as of 31 March 2026
Treasury shares 12,548,735 shares Held in treasury as of 31 March 2026
Shares with voting rights 8,918,544,526 shares Ordinary shares carrying voting rights as of 31 March 2026
Ordinary share nominal value £0.01 per share Nominal value of each ordinary share
treasury shares financial
"of which 12,548,735 are held as treasury shares."
Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.
voting rights financial
"Therefore, the number of ordinary shares with voting rights is 8,918,544,526"
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
Disclosure Guidance and Transparency Rules regulatory
"under the FCA's Disclosure Guidance and Transparency Rules."
Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.
ordinary shares financial
"the total number of shares issued by Haleon plc ... is 8,931,093,261 ordinary shares of £0.01 each"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of April 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
01 April 2026 - “Total Voting Rights and Capital”
 
 
 
99.1
 
 
 
Haleon plc: Total Voting Rights and Capital
 
01 April 2026: As at 31 March 2026 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 8,931,093,261 ordinary shares of £0.01 each, of which 12,548,735 are held as treasury shares.
 
Therefore, the number of ordinary shares with voting rights is 8,918,544,526 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
Notifiable interests in Haleon may be sent to: company.secretary@haleon.com
 
Amanda Mellor
Company Secretary
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as AdvilCentrumOtrivinPanadolparodontaxPolidentSensodyneTheraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: April 01, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What is Haleon (HLN) total number of issued shares as of 31 March 2026?

Haleon has issued a total of 8,931,093,261 ordinary shares of £0.01 each as of 31 March 2026. This figure includes both shares in circulation and those held in treasury by the company.

How many Haleon (HLN) shares carry voting rights as of 31 March 2026?

As of 31 March 2026, Haleon has 8,918,544,526 ordinary shares with voting rights. Investors should use this number as the denominator when calculating whether they must notify their interest under FCA transparency rules.

How many Haleon (HLN) shares are held in treasury?

Haleon holds 12,548,735 ordinary shares in treasury as of 31 March 2026. Treasury shares are issued but do not carry voting rights or dividend entitlements while held by the company itself.

Why does Haleon (HLN) publish total voting rights and capital information?

Haleon publishes total voting rights and capital so investors know the correct denominator for calculating ownership percentages. This helps shareholders determine when they must notify holdings or changes under the FCA’s Disclosure Guidance and Transparency Rules.

Which email can investors use to send notifiable interests in Haleon (HLN)?

Notifiable interests in Haleon may be sent to company.secretary@haleon.com. This address is provided for shareholders and others who need to report their interests under applicable disclosure and transparency requirements.

What type of business is Haleon (HLN)?

Haleon is a consumer company focused on everyday health, with brands like Advil, Centrum, Panadol, Sensodyne and Voltaren. Its products span oral health, vitamins, pain relief, respiratory, digestive, and therapeutic skin health categories worldwide.